InforSense and Ingenuity Systems Join Forces to Deliver Integrated Pathway Analysis Workflows
News Dec 07, 2006
The partnership will provide integration capabilities between InforSense KDE and Ingenuity Pathway Analysis (IPA).
Ingenuity Systems has also joined the InforSense Open Workflow Partner Network.
The collaboration is made to allow customers, who have both InforSense KDE and IPA licenses, to build workflows incorporating newly available IPA nodes.
Customers will be able to use the IPA nodes as part of their existing and new KDE analysis workflows to enhance and expand their use of IPA.
The IPA functionality available through the KDE workflow allows data to be uploaded and analyzed automatically.
In addition, users can view gene and gene neighbor information generated from a KDE workflow. The nodes are available now through InforSense.
“The collaboration between InforSense and Ingenuity Systems will provide life science researchers with a streamlined way to perform robust analysis and quickly identify biological relationships that are most relevant to their research for optimized decision-making,” said Tuan Nguyen, VP, Partner and Professional Services of Ingenuity Systems.
“InforSense workflows enable life science researchers to seamlessly link to IPA pathway data and custom build their analyses in a visual environment.”
“Pathway analysis is a fundamental part of the research process in the life sciences, particularly within the pharmaceutical industry, and we are pleased to be working with Ingenuity in this area,” commented Dr. Jonathan Sheldon, Chief Scientific Officer, InforSense.
“Integrating the value, which Ingenuity Pathway Analysis already provides to researchers together with the InforSense Life Science platform, is proving to be a beneficial addition to our multidisciplinary analytic workflows.”
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019